Multidrug Resistant Tuberculosis (MDR TB) occurs when the bacterium Mycobacterium tuberculosis becomes resistant to at least isoniazid and rifampicin, the two most potent TB drugs. These drugs are the cornerstone of first-line treatment for TB, and resistance to them makes the disease much harder to treat.